Drilldown: Medicines - Pharmacopedia

Nav

Choose a table:

Medicines (732)

Medicines > routes: subcutaneous

& onset

: Motor improvement over days at therapeutic dose

or Over weeks

Use the filters below to narrow your results.

None (2)

Ajovy (1) · Emgality (1)

Anti-CGRP ligand monoclonal antibody (2)

Humanized IgG2 monoclonal antibody binding both isoforms of CGRP peptide (1) · Humanized IgG4 monoclonal antibody binding CGRP peptide; prevents CGRP from activating its receptor (1)

Preventive treatment of migraine in adults (episodic and chronic) (1) · Preventive treatment of migraine in adults; episodic cluster headache (1)

225 mg SC monthly, or 675 mg SC every 3 months (quarterly) (1) · Migraine: 240 mg SC loading dose, then 120 mg SC monthly. Cluster: 300 mg SC at onset of cluster period, then monthly during cluster. (1)

120 mg/mL prefilled syringe or autoinjector (1) · 225 mg/1.5 mL prefilled syringe or autoinjector (1)

240 mg loading + 120 mg/month for migraine; 300 mg/month for cluster (1) · 675 mg/quarter (1)

Monthly dosing (1) · Monthly or quarterly dosing (1)

~27 days (1) · ~31 days (1)

Not formally established (1) · Not formally established (high SC) (1)

Limited data; avoid (2)

Rx (2)

Showing below up to 2 results in range #1 to #2.

F

Fremanezumab

G

Galcanezumab

Retrieved from "https://pharmacopedia.wiki/p/Special:Drilldown/Medicines"